Holdin announced the Company will exhibit two posters at the European Society of Gene and Cell Therapy 2025 Annual Congress, which ...

The library was constructed by generating a variety of AAV capsid variants through the insertion of random peptides at a specific site in the capsid. Specifically, a 7-mer peptide display library ...

Researchers identified immune cells that attacked the neuronal protein C9orf72 in individuals with ALS, spurring new ...

A major challenge in AAV gene therapy has been developing scalable, cost-efficient processes to reliably produce high-quality vectors.

Asimov has introduced a new manufacturing platform aimed at improving the scalability and consistency of AAV production for gene therapies.

Lonza Group AG has broadened its suite of CGT manufacturing solutions with 2 new products: TheraPEAK AmpliCell Cytokines and ...

In this webinar, Stefanie Müthel and Jessica Fiege will discuss how electroporation using the latest technology boosts cell ...